Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wafer-level burn-in may be Aehr Test Systems� technical edge, yet investors often just want to know who is buying stock, how margins move, or whether new EV design wins are material. That information is scattered across hundreds of pages and several form types—especially when you search for “Aehr Test Systems SEC filings explained simply.� The same hunt includes the “Aehr Test Systems quarterly earnings report 10-Q filing� and “Aehr Test Systems insider trading Form 4 transactions,� turning routine research into a time drain.
Stock Titan’s platform removes that friction. Our AI-powered summaries break down every section of the annual report—search “Aehr Test Systems annual report 10-K simplified� and jump straight to key risk factors. Receive real-time alerts for “Aehr Test Systems Form 4 insider transactions real-time,� so you see executive stock moves minutes after they hit EDGAR. New design-win announcements? We flag them the moment the company files an 8-K, giving you “Aehr Test Systems 8-K material events explained� in plain English.
Whether you’re comparing backlog growth across quarters or vetting “Aehr Test Systems executive stock transactions Form 4,� our coverage spans every disclosure type:
- AI-generated “Aehr Test Systems earnings report filing analysis� with side-by-side trend charts
- Guided walkthroughs for “understanding Aehr Test Systems SEC documents with AI�
- Red-lined changes in the preliminary “Aehr Test Systems proxy statement executive compensation� so pay packages are clear
No more digging through PDFs—our expert analysis, real-time updates, and full Form library put the critical data points in context, letting you act before the market does.
On 07/11/2025, Aehr Test Systems (AEHR) filed a Form 4 detailing a routine Code F transaction by Vice President Alistair N. Sporck. The company withheld 312 common shares at an implied price of $14.11 to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs); no open-market sale occurred. After the withholding, Sporck’s direct ownership totals 33,808 shares, with an additional 3,993 shares held indirectly through a trust. The total includes unvested RSUs, and no derivative securities were involved. Because the activity is purely administrative and does not alter the insider’s investment exposure, the filing is viewed as neutral for investors.
Aehr Test Systems (AEHR) filed a Form 4 disclosing that President & CEO Gayn Erickson had 2,489 common shares withheld on 07/11/2025 (transaction code F) at a price of $14.11 per share. The shares were automatically withheld by the issuer to cover statutory tax obligations triggered by the vesting of previously granted equity awards; no open-market sale occurred. After the withholding, Erickson retains 278,081 shares held directly and 291,088 shares held indirectly through a trust. The reported withholding represents less than 1 % of the executive’s aggregate beneficial ownership and does not signal a discretionary reduction in exposure to AEHR stock.
On July 11, 2025, Aehr Test Systems (ticker AEHR) Chief Operating Officer Adil Engineer filed a Form 4 reporting an administrative share disposition. The filing shows a Transaction Code "F," signifying that 580 common shares were automatically withheld at $14.11 each to cover tax obligations arising from the vesting of restricted stock units (RSUs). The aggregate value is roughly $8.2 thousand.
After the withholding, the executive continues to directly own 47,167 common shares, which includes unvested RSUs (as noted in footnote 2). No derivative securities were acquired or disposed of, and there were no open-market sales. Because the transaction is non-discretionary and involves a small share count relative to the officer’s total holdings, it is viewed as neutral in terms of market impact.
Aehr Test Systems (AEHR) Form 4 Filing Overview
Director Fariba Danesh reported the receipt of 9,253 shares of AEHR common stock on July 2, 2025 under a restricted stock unit (RSU) award, coded “A� for acquisition at a price of $0. After the grant, Danesh directly owns 25,643 shares, a total that includes unvested RSUs. The award vests in equal one-eighth installments every three months, contingent upon continued service on the board. No derivative securities were exercised or disposed of, and no open-market transactions occurred.
The filing appears to be part of routine director compensation rather than a discretionary purchase or sale. As such, it does not signal a material shift in ownership structure or insider sentiment, but it does modestly increase the director’s equity alignment with shareholders.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
